Annual ROE
156.79%
+33.94%+27.63%
31 December 2023
Summary:
UroGen Pharma annual return on equity is currently 156.79%, with the most recent change of +33.94% (+27.63%) on 31 December 2023. During the last 3 years, it has risen by +368.34% (+174.11%). URGN annual ROE is now at all-time high.URGN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
932.03%
+543.79%+140.07%
30 September 2024
Summary:
UroGen Pharma quarterly return on equity is currently 932.03%, with the most recent change of +543.79% (+140.07%) on 30 September 2024. Over the past year, it has increased by +819.11% (+725.39%). URGN quarterly ROE is now at all-time high.URGN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
URGN ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +725.4% |
| 3 y3 years | +174.1% | +552.6% |
| 5 y5 years | +301.6% | +1776.6% |
URGN ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +174.1% | at high | +162.7% |
| 5 y | 5 years | at high | +174.1% | at high | +162.7% |
| alltime | all time | at high | +174.1% | at high | +162.7% |
UroGen Pharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 932.03%(+140.1%) |
| June 2024 | - | 388.24%(+165.9%) |
| Mar 2024 | - | 146.01%(+29.3%) |
| Dec 2023 | 156.79%(+27.6%) | 112.92%(+3.8%) |
| Sept 2023 | - | 108.81%(+1.7%) |
| June 2023 | - | 107.01%(-25.7%) |
| Mar 2023 | - | 143.95%(-31.0%) |
| Dec 2022 | 122.85%(-158.1%) | 208.48%(-46.2%) |
| Sept 2022 | - | 387.62%(-126.1%) |
| June 2022 | - | -1487.50%(+308.8%) |
| Mar 2022 | - | -363.91%(+76.7%) |
| Dec 2021 | -211.55%(+127.8%) | -205.93%(+39.1%) |
| Sept 2021 | - | -148.08%(+30.8%) |
| June 2021 | - | -113.24%(+13.9%) |
| Mar 2021 | - | -99.43%(+6.8%) |
| Dec 2020 | -92.88% | -93.06%(+9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | -85.07%(+18.6%) |
| June 2020 | - | -71.70%(+18.7%) |
| Mar 2020 | - | -60.38%(+8.6%) |
| Dec 2019 | -77.77%(-18.5%) | -55.59%(+7.5%) |
| Sept 2019 | - | -51.72%(-9.5%) |
| June 2019 | - | -57.14%(-8.4%) |
| Mar 2019 | - | -62.41%(-17.6%) |
| Dec 2018 | -95.40%(+102.3%) | -75.72%(+18.6%) |
| Sept 2018 | - | -63.84%(+39.4%) |
| June 2018 | - | -45.80%(+9.8%) |
| Mar 2018 | - | -41.73%(+22.7%) |
| Dec 2017 | -47.16%(+296.0%) | -34.02%(-727.7%) |
| Sept 2017 | - | 5.42%(-152.3%) |
| June 2017 | - | -10.36%(-6.1%) |
| Mar 2017 | - | -11.03%(-211.1%) |
| Dec 2016 | -11.91%(-84.7%) | 9.93% |
| Dec 2015 | -77.94% | - |
FAQ
- What is UroGen Pharma annual return on equity?
- What is the all time high annual ROE for UroGen Pharma?
- What is UroGen Pharma quarterly return on equity?
- What is the all time high quarterly ROE for UroGen Pharma?
- What is UroGen Pharma quarterly ROE year-on-year change?
What is UroGen Pharma annual return on equity?
The current annual ROE of URGN is 156.79%
What is the all time high annual ROE for UroGen Pharma?
UroGen Pharma all-time high annual return on equity is 156.79%
What is UroGen Pharma quarterly return on equity?
The current quarterly ROE of URGN is 932.03%
What is the all time high quarterly ROE for UroGen Pharma?
UroGen Pharma all-time high quarterly return on equity is 932.03%
What is UroGen Pharma quarterly ROE year-on-year change?
Over the past year, URGN quarterly return on equity has changed by +819.11% (+725.39%)